ID   ACOC_HUMAN              Reviewed;         889 AA.
AC   P21399; D3DRK7; Q14652; Q5VZA7;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 3.
DT   10-MAY-2017, entry version 180.
DE   RecName: Full=Cytoplasmic aconitate hydratase;
DE            Short=Aconitase;
DE            EC=4.2.1.3;
DE   AltName: Full=Citrate hydro-lyase;
DE   AltName: Full=Ferritin repressor protein;
DE   AltName: Full=Iron regulatory protein 1;
DE            Short=IRP1;
DE   AltName: Full=Iron-responsive element-binding protein 1;
DE            Short=IRE-BP 1;
GN   Name=ACO1; Synonyms=IREB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1738601; DOI=10.1093/nar/20.1.33;
RA   Hirling H., Emery-Goodman A., Thompson N., Neupert B., Seiser C.,
RA   Kuehn L.;
RT   "Expression of active iron regulatory factor from a full-length human
RT   cDNA by in vitro transcription/translation.";
RL   Nucleic Acids Res. 20:33-39(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 74-889, RNA-BINDING, AND PARTIAL PROTEIN
RP   SEQUENCE.
RX   PubMed=2172968; DOI=10.1073/pnas.87.20.7958;
RA   Rouault T.A., Tang C.K., Kaptain S., Burgess W.H., Haile D.J.,
RA   Samaniego F., McBride O.W., Harford J.B., Klausner R.D.;
RT   "Cloning of the cDNA encoding an RNA regulatory protein -- the human
RT   iron-responsive element-binding protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:7958-7962(1990).
RN   [7]
RP   SIMILARITY TO ACONITASES AND IPM ISOMERASES.
RX   PubMed=1903202; DOI=10.1093/nar/19.8.1739;
RA   Hentze M.W., Argos P.;
RT   "Homology between IRE-BP, a regulatory RNA-binding protein, aconitase,
RT   and isopropylmalate isomerase.";
RL   Nucleic Acids Res. 19:1739-1740(1991).
RN   [8]
RP   FUNCTION AS AN ACONITASE.
RX   PubMed=1946430; DOI=10.1073/pnas.88.22.10109;
RA   Kaptain S., Downey W.E., Tang C.K., Philpott C., Haile D.J.,
RA   Orloff D.G., Harford J.B., Rouault T.A., Klausner R.D.;
RT   "A regulated RNA binding protein also possesses aconitase activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:10109-10113(1991).
RN   [9]
RP   FUNCTION, AND MUTAGENESIS OF CYS-300; CYS-437; CYS-503; CYS-506;
RP   ARG-536; ARG-541; ARG-699; SER-778 AND ARG-780.
RX   PubMed=8041788; DOI=10.1073/pnas.91.15.7321;
RA   Philpott C.C., Klausner R.D., Rouault T.A.;
RT   "The bifunctional iron-responsive element binding protein/cytosolic
RT   aconitase: the role of active-site residues in ligand binding and
RT   regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:7321-7325(1994).
RN   [10]
RP   UBIQUITINATION, AND INTERACTION WITH FBXL5.
RX   PubMed=19762596; DOI=10.1126/science.1176333;
RA   Vashisht A.A., Zumbrennen K.B., Huang X., Powers D.N., Durazo A.,
RA   Sun D., Bhaskaran N., Persson A., Uhlen M., Sangfelt O., Spruck C.,
RA   Leibold E.A., Wohlschlegel J.A.;
RT   "Control of iron homeostasis by an iron-regulated ubiquitin ligase.";
RL   Science 326:718-721(2009).
RN   [11]
RP   UBIQUITINATION, AND INTERACTION WITH FBXL5.
RX   PubMed=19762597; DOI=10.1126/science.1176326;
RA   Salahudeen A.A., Thompson J.W., Ruiz J.C., Ma H.-W., Kinch L.N.,
RA   Li Q., Grishin N.V., Bruick R.K.;
RT   "An E3 ligase possessing an iron responsive hemerythrin domain is a
RT   regulator of iron homeostasis.";
RL   Science 326:722-726(2009).
RN   [12]
RP   INTERACTION WITH FRATAXIN(81-210).
RX   PubMed=20053667; DOI=10.1093/hmg/ddp592;
RA   Condo I., Malisan F., Guccini I., Serio D., Rufini A., Testi R.;
RT   "Molecular control of the cytosolic aconitase/IRP1 switch by
RT   extramitochondrial frataxin.";
RL   Hum. Mol. Genet. 19:1221-1229(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-628, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) IN COMPLEX WITH IRON-SULFUR
RP   CLUSTER, AND COFACTOR.
RX   PubMed=16407072; DOI=10.1016/j.str.2005.09.009;
RA   Dupuy J., Volbeda A., Carpentier P., Darnault C., Moulis J.-M.,
RA   Fontecilla-Camps J.C.;
RT   "Crystal structure of human iron regulatory protein 1 as cytosolic
RT   aconitase.";
RL   Structure 14:129-139(2006).
RN   [16]
RP   VARIANT MET-318.
RX   PubMed=23033978; DOI=10.1056/NEJMoa1206524;
RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,
RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P.,
RA   Gilissen C., del Rosario M., Hoischen A., Scheffer H., de Vries B.B.,
RA   Brunner H.G., Veltman J.A., Vissers L.E.;
RT   "Diagnostic exome sequencing in persons with severe intellectual
RT   disability.";
RL   N. Engl. J. Med. 367:1921-1929(2012).
CC   -!- FUNCTION: Iron sensor. Binds a 4Fe-4S cluster and functions as
CC       aconitase when cellular iron levels are high. Functions as mRNA
CC       binding protein that regulates uptake, sequestration and
CC       utilization of iron when cellular iron levels are low. Binds to
CC       iron-responsive elements (IRES) in target mRNA species when iron
CC       levels are low. Binding of a 4Fe-4S cluster precludes RNA binding.
CC       {ECO:0000269|PubMed:1946430, ECO:0000269|PubMed:8041788}.
CC   -!- FUNCTION: Catalyzes the isomerization of citrate to isocitrate via
CC       cis-aconitate. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: Citrate = isocitrate.
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000269|PubMed:16407072};
CC       Note=Binds 1 [4Fe-4S] cluster per subunit.
CC       {ECO:0000269|PubMed:16407072};
CC   -!- SUBUNIT: Interacts (when associated with the 4Fe-4S) with FBXL5.
CC       Interacts with frataxin(81-210). {ECO:0000269|PubMed:16407072,
CC       ECO:0000269|PubMed:19762596, ECO:0000269|PubMed:19762597,
CC       ECO:0000269|PubMed:20053667}.
CC   -!- INTERACTION:
CC       P20929:NEB; NbExp=2; IntAct=EBI-2847111, EBI-1049657;
CC       Q13326:SGCG; NbExp=2; IntAct=EBI-2847111, EBI-5357343;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- SIMILARITY: Belongs to the aconitase/IPM isomerase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Aconitase entry;
CC       URL="https://en.wikipedia.org/wiki/Aconitase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z11559; CAA77651.1; -; mRNA.
DR   EMBL; DQ496106; ABF47095.1; -; Genomic_DNA.
DR   EMBL; AL161783; CAH72598.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58549.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58550.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58552.1; -; Genomic_DNA.
DR   EMBL; BC018103; AAH18103.1; -; mRNA.
DR   EMBL; M58510; AAA69900.1; -; mRNA.
DR   CCDS; CCDS6525.1; -.
DR   PIR; S26403; S26403.
DR   RefSeq; NP_001265281.1; NM_001278352.1.
DR   RefSeq; NP_002188.1; NM_002197.2.
DR   RefSeq; XP_005251533.1; XM_005251476.1.
DR   RefSeq; XP_011516190.1; XM_011517888.1.
DR   UniGene; Hs.567229; -.
DR   PDB; 2B3X; X-ray; 2.54 A; A=2-889.
DR   PDB; 2B3Y; X-ray; 1.85 A; A/B=2-889.
DR   PDBsum; 2B3X; -.
DR   PDBsum; 2B3Y; -.
DR   ProteinModelPortal; P21399; -.
DR   SMR; P21399; -.
DR   BioGrid; 106564; 17.
DR   IntAct; P21399; 9.
DR   STRING; 9606.ENSP00000309477; -.
DR   DrugBank; DB06757; Manganese.
DR   MoonProt; P21399; -.
DR   iPTMnet; P21399; -.
DR   PhosphoSitePlus; P21399; -.
DR   SwissPalm; P21399; -.
DR   BioMuta; ACO1; -.
DR   DMDM; 3123225; -.
DR   REPRODUCTION-2DPAGE; IPI00008485; -.
DR   UCD-2DPAGE; P21399; -.
DR   EPD; P21399; -.
DR   PaxDb; P21399; -.
DR   PeptideAtlas; P21399; -.
DR   PRIDE; P21399; -.
DR   Ensembl; ENST00000309951; ENSP00000309477; ENSG00000122729.
DR   Ensembl; ENST00000379923; ENSP00000369255; ENSG00000122729.
DR   Ensembl; ENST00000541043; ENSP00000438733; ENSG00000122729.
DR   GeneID; 48; -.
DR   KEGG; hsa:48; -.
DR   CTD; 48; -.
DR   DisGeNET; 48; -.
DR   GeneCards; ACO1; -.
DR   HGNC; HGNC:117; ACO1.
DR   HPA; HPA019371; -.
DR   HPA; HPA024157; -.
DR   MIM; 100880; gene.
DR   neXtProt; NX_P21399; -.
DR   OpenTargets; ENSG00000122729; -.
DR   PharmGKB; PA24442; -.
DR   eggNOG; KOG0452; Eukaryota.
DR   eggNOG; COG1048; LUCA.
DR   GeneTree; ENSGT00860000133751; -.
DR   HOGENOM; HOG000025704; -.
DR   HOVERGEN; HBG052147; -.
DR   InParanoid; P21399; -.
DR   KO; K01681; -.
DR   OMA; ENLAKWG; -.
DR   OrthoDB; EOG091G01IX; -.
DR   PhylomeDB; P21399; -.
DR   TreeFam; TF313476; -.
DR   BioCyc; MetaCyc:HS04597-MONOMER; -.
DR   BRENDA; 4.2.1.3; 2681.
DR   SIGNOR; P21399; -.
DR   ChiTaRS; ACO1; human.
DR   EvolutionaryTrace; P21399; -.
DR   GenomeRNAi; 48; -.
DR   PRO; PR:P21399; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000122729; -.
DR   CleanEx; HS_ACO1; -.
DR   ExpressionAtlas; P21399; baseline and differential.
DR   Genevisible; P21399; HS.
DR   GO; GO:0005737; C:cytoplasm; IMP:CAFA.
DR   GO; GO:0005829; C:cytosol; IDA:HGNC.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:MGI.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0051538; F:3 iron, 4 sulfur cluster binding; IMP:CAFA.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:UniProtKB.
DR   GO; GO:0003994; F:aconitate hydratase activity; IDA:UniProtKB.
DR   GO; GO:0030350; F:iron-responsive element binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:Ensembl.
DR   GO; GO:0006101; P:citrate metabolic process; IDA:UniProtKB.
DR   GO; GO:0050892; P:intestinal absorption; IEA:Ensembl.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0006417; P:regulation of translation; IEA:Ensembl.
DR   GO; GO:0010040; P:response to iron(II) ion; IDA:UniProtKB.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-KW.
DR   Gene3D; 3.20.19.10; -; 1.
DR   Gene3D; 3.30.499.10; -; 2.
DR   Gene3D; 3.40.1060.10; -; 1.
DR   InterPro; IPR015931; Acnase/IPM_dHydase_lsu_aba_1/3.
DR   InterPro; IPR001030; Acoase/IPM_deHydtase_lsu_aba.
DR   InterPro; IPR015928; Aconitase/3IPM_dehydase_swvl.
DR   InterPro; IPR015932; Aconitase/IPMdHydase_lsu_aba_2.
DR   InterPro; IPR006249; Aconitase/IRP2.
DR   InterPro; IPR018136; Aconitase_4Fe-4S_BS.
DR   InterPro; IPR000573; AconitaseA/IPMdHydase_ssu_swvl.
DR   InterPro; IPR029784; IRE-BP1.
DR   PANTHER; PTHR11670; PTHR11670; 1.
DR   PANTHER; PTHR11670:SF47; PTHR11670:SF47; 1.
DR   Pfam; PF00330; Aconitase; 1.
DR   Pfam; PF00694; Aconitase_C; 1.
DR   PRINTS; PR00415; ACONITASE.
DR   SUPFAM; SSF52016; SSF52016; 1.
DR   SUPFAM; SSF53732; SSF53732; 1.
DR   TIGRFAMs; TIGR01341; aconitase_1; 1.
DR   PROSITE; PS00450; ACONITASE_1; 1.
DR   PROSITE; PS01244; ACONITASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; 4Fe-4S; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Iron; Iron-sulfur; Lyase; Metal-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; RNA-binding;
KW   Tricarboxylic acid cycle.
FT   CHAIN         1    889       Cytoplasmic aconitate hydratase.
FT                                /FTId=PRO_0000076680.
FT   REGION      205    207       Substrate binding. {ECO:0000250}.
FT   REGION      779    780       Substrate binding. {ECO:0000250}.
FT   METAL       437    437       Iron-sulfur (4Fe-4S). {ECO:0000250}.
FT   METAL       503    503       Iron-sulfur (4Fe-4S). {ECO:0000250}.
FT   METAL       506    506       Iron-sulfur (4Fe-4S). {ECO:0000250}.
FT   BINDING      86     86       Substrate. {ECO:0000250}.
FT   BINDING     536    536       Substrate. {ECO:0000250}.
FT   BINDING     541    541       Substrate. {ECO:0000250}.
FT   BINDING     699    699       Substrate. {ECO:0000250}.
FT   MOD_RES     628    628       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VARIANT     318    318       T -> M (in dbSNP:rs150373174).
FT                                {ECO:0000269|PubMed:23033978}.
FT                                /FTId=VAR_069413.
FT   VARIANT     395    395       A -> D (in dbSNP:rs3814519).
FT                                /FTId=VAR_048180.
FT   VARIANT     486    486       G -> R (in dbSNP:rs34630459).
FT                                /FTId=VAR_048181.
FT   MUTAGEN     300    300       C->S: No effect on aconitase activity or
FT                                on RNA binding.
FT                                {ECO:0000269|PubMed:8041788}.
FT   MUTAGEN     437    437       C->S: Loss of aconitase activity. Leads
FT                                to constitutive RNA binding, irrespective
FT                                of iron levels.
FT                                {ECO:0000269|PubMed:8041788}.
FT   MUTAGEN     503    503       C->S: Loss of aconitase activity. Leads
FT                                to constitutive RNA binding, irrespective
FT                                of iron levels.
FT                                {ECO:0000269|PubMed:8041788}.
FT   MUTAGEN     506    506       C->S: Loss of aconitase activity. Leads
FT                                of iron levels.
FT                                {ECO:0000269|PubMed:8041788}.
FT   MUTAGEN     536    536       R->Q: Strongly reduced RNA binding.
FT                                {ECO:0000269|PubMed:8041788}.
FT   MUTAGEN     541    541       R->Q: Strongly reduced RNA binding.
FT                                {ECO:0000269|PubMed:8041788}.
FT   MUTAGEN     699    699       R->K: No effect on RNA binding.
FT                                {ECO:0000269|PubMed:8041788}.
FT   MUTAGEN     778    778       S->A: No effect on iron-regulated RNA
FT                                binding. Loss of aconitase activity.
FT                                {ECO:0000269|PubMed:8041788}.
FT   MUTAGEN     780    780       R->Q: Nearly abolishes RNA binding.
FT                                {ECO:0000269|PubMed:8041788}.
FT   HELIX         6      8       {ECO:0000244|PDB:2B3Y}.
FT   STRAND        9     12       {ECO:0000244|PDB:2B3Y}.
FT   STRAND       20     22       {ECO:0000244|PDB:2B3Y}.
FT   HELIX        24     27       {ECO:0000244|PDB:2B3Y}.
FT   HELIX        32     34       {ECO:0000244|PDB:2B3Y}.
FT   HELIX        37     48       {ECO:0000244|PDB:2B3Y}.
FT   STRAND       52     55       {ECO:0000244|PDB:2B3Y}.
FT   HELIX        57     64       {ECO:0000244|PDB:2B3Y}.
FT   HELIX        66     69       {ECO:0000244|PDB:2B3Y}.
FT   TURN         70     73       {ECO:0000244|PDB:2B3Y}.
FT   STRAND       75     78       {ECO:0000244|PDB:2B3Y}.
FT   STRAND       81     86       {ECO:0000244|PDB:2B3Y}.
FT   HELIX        87    106       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       111    113       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      120    123       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       138    163       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      167    170       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       177    183       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      188    192       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      195    198       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      200    205       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       206    214       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      217    220       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       223    230       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      235    238       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      242    249       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       257    271       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      277    282       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       283    285       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       290    298       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       300    303       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      306    309       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       314    322       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       327    340       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       349    351       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      356    362       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       363    365       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      368    371       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      379    381       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       382    384       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       385    394       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       406    408       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      412    417       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      420    425       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      428    434       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       437    440       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       443    458       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      467    471       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       476    484       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       488    493       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      501    503       {ECO:0000244|PDB:2B3X}.
FT   HELIX       504    507       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       515    524       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      529    535       {ECO:0000244|PDB:2B3Y}.
FT   TURN        539    541       {ECO:0000244|PDB:2B3X}.
FT   STRAND      547    551       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       554    563       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      564    566       {ECO:0000244|PDB:2B3X}.
FT   TURN        570    572       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      575    578       {ECO:0000244|PDB:2B3Y}.
FT   TURN        579    581       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      582    584       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       586    589       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       593    603       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       606    613       {ECO:0000244|PDB:2B3Y}.
FT   TURN        614    618       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       621    625       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       647    649       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      662    671       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       677    680       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      688    690       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       691    698       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       703    705       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       710    712       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       716    721       {ECO:0000244|PDB:2B3Y}.
FT   TURN        722    724       {ECO:0000244|PDB:2B3Y}.
FT   TURN        732    734       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      735    737       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      739    742       {ECO:0000244|PDB:2B3Y}.
FT   TURN        744    746       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      749    751       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       752    761       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      766    769       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      772    774       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       782    789       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      792    798       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       802    810       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      814    818       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       824    827       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      835    837       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      848    853       {ECO:0000244|PDB:2B3Y}.
FT   STRAND      858    863       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       868    876       {ECO:0000244|PDB:2B3Y}.
FT   HELIX       879    888       {ECO:0000244|PDB:2B3Y}.
SQ   SEQUENCE   889 AA;  98399 MW;  E1A05AF701D46DCB CRC64;
     MSNPFAHLAE PLDPVQPGKK FFNLNKLEDS RYGRLPFSIR VLLEAAIRNC DEFLVKKQDI
     ENILHWNVTQ HKNIEVPFKP ARVILQDFTG VPAVVDFAAM RDAVKKLGGD PEKINPVCPA
     DLVIDHSIQV DFNRRADSLQ KNQDLEFERN RERFEFLKWG SQAFHNMRII PPGSGIIHQV
     NLEYLARVVF DQDGYYYPDS LVGTDSHTTM IDGLGILGWG VGGIEAEAVM LGQPISMVLP
     QVIGYRLMGK PHPLVTSTDI VLTITKHLRQ VGVVGKFVEF FGPGVAQLSI ADRATIANMC
     PEYGATAAFF PVDEVSITYL VQTGRDEEKL KYIKKYLQAV GMFRDFNDPS QDPDFTQVVE
     LDLKTVVPCC SGPKRPQDKV AVSDMKKDFE SCLGAKQGFK GFQVAPEHHN DHKTFIYDNT
     EFTLAHGSVV IAAITSCTNT SNPSVMLGAG LLAKKAVDAG LNVMPYIKTS LSPGSGVVTY
     YLQESGVMPY LSQLGFDVVG YGCMTCIGNS GPLPEPVVEA ITQGDLVAVG VLSGNRNFEG
     RVHPNTRANY LASPPLVIAY AIAGTIRIDF EKEPLGVNAK GQQVFLKDIW PTRDEIQAVE
     RQYVIPGMFK EVYQKIETVN ESWNALATPS DKLFFWNSKS TYIKSPPFFE NLTLDLQPPK
     SIVDAYVLLN LGDSVTTDHI SPAGNIARNS PAARYLTNRG LTPREFNSYG SRRGNDAVMA
     RGTFANIRLL NRFLNKQAPQ TIHLPSGEIL DVFDAAERYQ QAGLPLIVLA GKEYGAGSSR
     DWAAKGPFLL GIKAVLAESY ERIHRSNLVG MGVIPLEYLP GENADALGLT GQERYTIIIP
     ENLKPQMKVQ VKLDTGKTFQ AVMRFDTDVE LTYFLNGGIL NYMIRKMAK
//
